Skip to content

Clinical trials

Respiratory Tract Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Infections Country / region: China Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20094
20113
20131
20171
20203
20213
20227
20232
20244
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status7
Recruiting7
Not yet recruiting3
Active, not recruiting2
Terminated2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CanSino Biologics Inc.2
Hualan Biological Engineering, Inc.2
Huazhong University of Science and Technology2
Jiangsu Province Centers for Disease Control and Prevention2
Peking University People's Hospital2
Shenzhen Shenxin Biotechnology Co., Ltd2
Xiangbei Welman Pharmaceutical Co., Ltd2
Almirall, S.A.1
AstraZeneca1
Capital Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Infections38
Influenza, Human8
Virus Diseases7
Orthomyxoviridae Infections5
Pneumonia5
Respiratory Tract Diseases5
Infections4
Urinary Tract Infections3
Bacterial Infections2
Bronchitis2

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.